FDA Comes Under Fire From Sen. Clinton Over Plan B Decision
This article was originally published in The Tan Sheet
Executive Summary
Sen. Hillary Clinton (D-N.Y.) is calling for a hearing and separate GAO investigation into FDA's decision to deny OTC approval of Barr's Plan B (levenorgestrel) emergency contraceptive
You may also be interested in...
GAO Draft Report Finds Plan B Rejection “Unusual”; Lawmakers Urge Decision
The Government Accountability Office's investigation into FDA's initial denial of Plan B discovered that the agency's decision to issue a "not approvable" letter did not reflect the opinions of scientific review staff.
FDAer Resigns Over Plan B; Senators Seek Results Of GAO Investigation
FDA Office of Women's Health Director Susan Wood is resigning over the agency's handling of Barr Labs' application to switch its Plan B emergency contraceptive over-the-counter
Plan B Investigation May Get No HELP In Senate
FDA's handling of an emergency contraception switch may be less likely to come under investigation with new leadership on the Senate HELP committee